PlainRecalls

P&l Developments, LLC

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Oct 7, 2020

Subscribe to new P&l Developments, LLC recalls (RSS)

Agency notice ledger

Federal filing book P&l Developments, LLC LIGHT-BOOK · SINGLE-AGENCY

#2,245 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,245 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT drugs
  • CATS 2 categories
  • LATEST Oct 7, 2020
  • PHOTO 1908 Brands

Nearest notice-volume peer: 1908 Brands (0 notice gap)

P&l Developments, LLC accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where P&l Developments, LLC sits among 14,151 recalling firms

P&l Developments, LLC ranks 2,245th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

P&l Developments, LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2245th of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

P&l Developments, LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows P&l Developments, LLC holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Oct 7, 2020

Nicotine Gum, Nicotine Polacrilex Gum USP, 2 mg (nicotine), 110-count pieces per carton, Distributed By: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-3328-3.
FDA Drug Moderate Jun 26, 2019

Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. (118 mL) Bottle, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-178-04, UPC 359726178044.
FDA Drug Moderate Jun 26, 2019

Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Gluten Free, Grape Flavor, 5 mg/5mL, 4 FL. oz. Bottle, Distributed by Dolgencorp, LLC, 100 mission ridge, Goodlettsville, TN 37072, NDC 55910-878-04, UPC 359726178051.
FDA Drug Moderate Jun 26, 2019

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.
FDA Drug Low May 7, 2014

Children's Triacting Night Time Cold & Cough with PE (diphenhydramine hcl and phenylephrine hcl), Grape Flavor, For Ages 6 to 11, 4 fl oz Bottles, liquid. Labeled A) aaron health KIDS, Manufactured by: Aaron Industries, P.O. Box 801, Lynwood, CA 90262. UPC: 7 15256 72204 9. B) FAMILY wellness, Distributed By: Family Dollar Services, Inc., 10401 Monroe Rd, Matthews, NC 28105. UPC: 0 32251 03394 0. C) Good Neighbor Pharmacy. Distributed By: AmerisourceBergen, 1300 Morris Drive, Chesterbrook, PA

FDA Drug Low Apr 30, 2014

Day Time Cold & Flu, Multi-Symptom, Non-Drowsy, Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 4, 6, 8, 10, and 12 oz Bottles, OTC Only. Labeled A) Aaron Health, 10 FL OZ, Manufactured by Aaron Industries, P.O. Box 801, Lynwood, CA 90262, UPC: 7 15256 73510 0; B) Aaron Health, 8 FL OZ, Manufactured by: PL Developments, 11865 S. Alameda St, Lynwood, CA 90262, UPC: 7 15256 71428 0; C) Aaron Brands, 6 FL OZ, Manufactured by: Aaron Industries, Inc., P.O. Box 801, Lynwood, CA 90262, UPC: 7

P&l Developments, LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

1908 Brands 6 Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aire-Master of America Inc 6 Apollo Care 6 Appco Pharma LLC 6 Aspen Biopharma Labs Pvt., Ltd. 6

Frequently Asked Questions

How many federal recall notices name P&l Developments, LLC? ▼
PlainRecalls indexes 6 distinct federal recall events naming P&l Developments, LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does P&l Developments, LLC sit among other recalling firms? ▼
P&l Developments, LLC ranks #2,245 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of P&l Developments, LLC's notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates P&l Developments, LLC's filing book? ▼
Filings for P&l Developments, LLC span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
P&l Developments, LLC: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming P&l Developments, LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026